Free Republic

At the start of the pandemic, researchers began testing existing antivirals in people hospitalized with severe Covid-19. But many of those trials failed to show any benefit from the antivirals. In hindsight, the choice to work in hospitals was a mistake. Scientists now know that the best time to try to block the coronavirus is in the first few days of the disease, when the virus is replicating rapidly and the immune system has not yet mounted a defense. In a trial of hospitalized patients, however, molnupiravir seemed to have no effect on the disease. In April, the companies announced...

President Donald J. Trump was sicker with Covid-19 in October than publicly acknowledged at the time, with extremely depressed blood oxygen levels at one point and a lung problem associated with pneumonia caused by the coronavirus, according to four people familiar with his condition. His prognosis became so worrisome before he was taken to Walter Reed National Military Medical Center that officials believed he would need to be put on a ventilator, two of the people familiar with his condition said. The people familiar with Mr. Trump’s health said he was found to have lung infiltrates, which occur when the...

https://twitter.com/VincentCrypt46/status/1261122553461923840 2 MIN VIDEO FROM THE iNGRAHAM ANGLE DR SAYS PEOPLE FEEL BETTER WITHIN 5 HOURS OF TAKING THE TRUMP COCKTAIL

India's Supreme Court refused an attempt by an NGO named People For Better Treatment to prevent the use of Hydroxychloroquinine and Azithromycin in treating critically ill COVID-19 patients. Freeper cba123 posted a thread about it.SC Refuses Plea Against Use Of Hydroxychloroquine & Azithromycin In Treatment Of COVID-19 (Legal - India) India Legal ^ | April 30, 2020, 12:45 pm Posted on 5/4/2020, 1:25:21 AM by cba123rnote: In post #3 of that FR thread, FReeper silverleaf remarked:Man, i bet this group is backed and funded by Gates They were actually trying to get the Indian govt to stop allowing doctors to...

A Randomized Clinical Trial KEY POINTSQuestion How safe and effective are 2 different regimens of chloroquine diphosphate in the treatment of severe coronavirus disease 2019 (COVID-19)? Findings In this phase IIb randomized clinical trial of 81 patients with COVID-19, an unplanned interim analysis recommended by an independent data safety and monitoring board found that a higher dosage of chloroquine diphosphate for 10 days was associated with more toxic effects and lethality, particularly affecting QTc interval prolongation. The limited sample size did not allow the study to show any benefit overall regarding treatment efficacy.Meaning The preliminary findings from the CloroCovid-19 trial...

Hit the source link to open a *.pdf of a flow chart procedure for treating COVID-19 inpatients. Look on the left hand side. The *.pdf document is from this web page at Yale: https://covid.yale.edu/clinical/protocol/

There is no news article by the Governor yet. However, Governor John Bel Edwards (Democrat) and Attorney General of Louisiana Jeff Landry (Republican) announced through a breaking news conference that Louisiana is making the anti-malarial drug 'hydrocholoroquine' and the anti-biotic available to doctors to prescribe in Louisiana for people with COVID-19 Justification: Gov. Edwards stated that such action would free up HOSPITAL BEDS and VENTILATORS in Louisiana. Pharmacies in Louisiana will have these drugs available through the Government of Louisiana distributing them.

President Donald Trump said U.S. health officials should have a “good idea” whether an anti-malaria drug being tested as a treatment for COVID-19 is effective in fighting the coronavirus in “the next three days.” “Hydroxychloroquine is something that I have been pushing very hard,” Trump said Monday morning during an interview on Fox News. “I think we’re going to have a good idea over the next three days because it’s been used now in New York at my request -- 1,100 people. It’s been used. I think that’s better than testing it in a laboratory. But the doctors tell me...

Patrick Rooney of Old School™ comments following the White House Coronavirus news briefing Sunday evening, March 29, 2019. The President extended "social distancing" guidelines until April 30th based on recommendations from his medical advisers Dr. Anthony Fauci and Dr. Deborah Birx. At the briefing, Dr. Fauci repeated this concern that 100-200,000 Americans could die from Coronavirus (COVID-19) if steps are not taken to prevent this. The President stated that the anti-malaria drug Hydrochloroquine is being tested in New York state, and that 1,100 are in a study. Governor Andrew Cuomo has given a directive that people outside the study group...

What are the Democrat governors in Nevada and Michigan going to do now? – The Food and Drug Administration issued an emergency use autorization on Sunday, approving hydroxycholoroquine and chloroquine for use in treating the Wuhan Virus, COVID-19, after numerous successful studies and test cases emerged over the past three weeks. Democrat politicians and corrupt media outlets who are hoping this crisis lasts as long as possible in order to damage President Trump have been despicably down-playing the use of this safe, well-known, inexpensive and plentiful malaria treatment for the past two weeks. Two Democrat hack governors – Steve Sisolak...

The U.S. Food and Drug Administration (FDA) has approved the use of two anti-malaria drugs to treat patients infected by the new coronavirus. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. (EUA) That marked the first EUA for a drug related to COVID-19 in the U.S., according to the statement. Currently, there are no specific drugs for COVID-19 which, as shown...

FDA issues emergency use authorization for donated hydroxychloroquine sulfate, chloroquine phosphate The U.S. Department of Health and Human Services (HHS) today accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials. These and other companies may donate additional doses, and companies have ramped up production to provide additional supplies of the medication to the commercial market. “President Trump is taking every possible step to protect Americans from the...

(CNN) — The US Food and Drug Administration (FDA) has issued an emergency use authorization for chloroquine and hydroxychloroquine to treat patients hospitalized with COVID-19. The drugs — which are used to treat malaria and other conditions — have been called game changers by President Donald Trump. But thus far, there is little scientific evidence that chloroquine, or its closely-related analogue hydroxychloroquine, are effective in treating Covid-19. What happened? The authorization came in a letter dated Saturday, but the US Department of Health and Human Services (HHS) acknowledged the FDA’s action in a Sunday news release. The FDA limited the...

The Food and Drug Administration on Sunday issued an emergency use authorization for hydroxychloroquine and chloroquine, decades-old malaria drugs championed by President Donald Trump for coronavirus treatment despite scant evidence. The agency allowed for the drugs to be "donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible," HHS said in a statement, announcing that Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine. (Please see link, for full...

Doctors in Italy have finally began widely prescribing hydroxychloroquine in certain combinations in Rome and the wider region of Lazio with a population of around six million. According to Corriere della Sera, a well known Italian daily newspaper, Dr. Pier Luigi Bartoletti, Deputy National Secretary of the Italian Federation of General Practitioners, explains that every single person with Covid-19 that has early signs, like a cough or a fever for example, is now being treated with the anti-malaria drug. The drug “is already giving good results,” Bartoletti says while Malaysia reveals they have been using it since the very beginning....

The chief executive of Novartis believes it will take at least 12 months to find a new vaccine to treat the coronavirus, with the fast-spreading nature of the outbreak a threat that must be taken “really seriously.” China’s National Health Commission confirmed Wednesday that the coronavirus had infected 5,974 people, with 132 deaths and 103 cured. The virus, which was first discovered in the Chinese city of Wuhan, has spread to other major cities such as Beijing, Shanghai, Macao and Hong Kong. The number of coronavirus cases in China has already surpassed that of severe acute respiratory syndrome, or SARS,...

ZURICH (Reuters) - Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday. Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which U.S. President Donald Trump also has been promoting, can be approved for use against the coronavirus. Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus. (Please see link, for full story)

Excerpt: ZURICH, March 29 (Reuters) - Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday. Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which U.S. President Donald Trump also has been promoting, can be approved for use against the coronavirus.

Excerpt: ..... She had to be hospitalized for five days at the V.A. in Long Beach, where her doctor approached her about a trial for hydroxychloroquine, a medication often used to treat auto-immune diseases like lupus. “It’s simple to take. It’s two little pills. They bring it in a little cup,” Paz said....

Four more state pharmacy boards have followed Ohio's lead and taken steps to block pharmacists from excessively dispensing two drugs touted as possible COVID-19 treatments, as both drugs are already in shortage. Utah, Idaho, Texas and Nevada have all moved to block unnecessary prescriptions of chloroquine and hydroxychloroquine, both designed to treat malaria but commonly used to treat autoimmune diseases such as lupus and rheumatoid arthritis. Both drugs have been shown to be effective in slowing the effects of COVID-19 in preliminary trials, but there is no evidence they treat the virus. Physicians were found to be writing prescriptions for...